Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021
This report describes COVID-19 vaccine administration by race in North Carolina.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=424600


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021
This report describes the Advisory Committee on Immunization Practices' (ACIP) conclusion that the benefits of COVID-19 vaccination outweigh the risks of myocarditis.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=424154


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021
Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421542


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic - United States, March-April 2021
Among 26,174 surveyed state, tribal, local, and territorial public health workers, 53% reported symptoms of at least one mental health condition in the past 2 weeks. Symptoms were more prevalent among those who were unable to take time off from work or who felt bullied, threatened, or harassed because of work.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423827


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
In U.S. hospitals during January-March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421438


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
Disparities in Learning Mode Access Among K-12 Students During the COVID-19 Pandemic, by Race/Ethnicity, Geography, and Grade Level - United States, September 2020-April 2021
Although access to in-person, hybrid, and virtual learning modes varied throughout the school year, during January-April 2021, access to full-time, in-person learning increased 37% for non-Hispanic White students, 31% for non-Hispanic Black students, 22% for Hispanic students, and 27% for students of other race/ethnicities.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423978


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021
This report describes an investigation in Maryland of two linked clusters of COVID-19 cases identified as the B.1.351 variant.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421458


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021
Overall, 34% of adults aged 18-39 years reported having received a COVID-19 vaccine. Adults aged 18-24 years, as well as non-Hispanic Black adults and those with less education, no health insurance, and lower household incomes, had the lowest reported vaccination coverage and intent to get vaccinated. Concerns about vaccine safety and effectiveness were commonly cited barriers to vaccination.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423690


27 Nisan 2022, Çarşamba, 00:06 Haber Kaynağı: Çeşitli Haber Siteleri
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021
The Advisory Committee on Immunization Practices concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged ≥18 years outweighed the risks and reaffirmed its interim recommendation under FDA's Emergency Use Authorization, which includes a new warning for rare clotting events among women aged 18-49 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421416